(R)-Lansoprazole-d4

• CAT Number: S000493
• CAS Number: 934294-22-1
• Molecular Formula: C16H10D4F3N3O2S
• Molecular Weight: 373.39
• Purity: ≥95%
• IUPAC Name: 4,5,6,7-tetradeuterio-2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
• InChI: InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/i2D,3D,4D,5D
• InChIKey: MJIHNNLFOKEZEW-QFFDRWTDSA-N
• SMILES: CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F

(R)-Lansoprazole-d4（Cat No.:S000493） is a deuterated version of (R)-lansoprazole, where four hydrogen atoms are replaced with deuterium. Lansoprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, commonly used to treat gastroesophageal reflux disease (GERD), ulcers, and Zollinger-Ellison syndrome. The (R)-enantiomer is one of the two optical isomers of lansoprazole, with potentially different pharmacokinetic properties from the (S)-enantiomer. Deuteration in (R)-Lansoprazole-d4 enhances its metabolic stability, facilitating more precise pharmacokinetic and metabolic studies to optimize dosing and effectiveness, while potentially reducing side effects.